A detailed history of Jpmorgan Chase & CO transactions in Illumina, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 635,403 shares of ILMN stock, worth $97.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
635,403
Previous 1,134,678 44.0%
Holding current value
$97.5 Million
Previous $156 Million 57.43%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$101.05 - $133.57 $50.5 Million - $66.7 Million
-499,275 Reduced 44.0%
635,403 $66.3 Million
Q1 2024

May 10, 2024

BUY
$127.73 - $147.2 $63.3 Million - $73 Million
495,853 Added 77.62%
1,134,678 $156 Million
Q4 2023

Feb 12, 2024

BUY
$92.79 - $142.53 $5.03 Million - $7.72 Million
54,194 Added 9.27%
638,825 $88.9 Million
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $14.3 Million - $21.3 Million
110,745 Added 23.37%
584,631 $80.3 Million
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $88.6 Million - $112 Million
-483,189 Reduced 50.49%
473,886 $88.8 Million
Q1 2023

May 18, 2023

BUY
$193.75 - $232.55 $14.3 Million - $17.2 Million
74,031 Added 8.38%
957,075 $223 Million
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $54.1 Million - $64.9 Million
279,263 Added 46.25%
883,044 $205 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $40.6 Million - $52.6 Million
216,856 Added 56.05%
603,781 $122 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $5.54 Million - $7.1 Million
31,235 Added 8.78%
386,925 $73.8 Million
Q2 2022

Aug 11, 2022

SELL
$181.58 - $368.0 $35.9 Million - $72.8 Million
-197,916 Reduced 35.75%
355,690 $65.6 Million
Q1 2022

May 11, 2022

BUY
$303.87 - $423.8 $58.4 Million - $81.5 Million
192,337 Added 53.24%
553,606 $193 Million
Q4 2021

Feb 10, 2022

SELL
$347.28 - $421.83 $53.8 Million - $65.4 Million
-155,008 Reduced 30.02%
361,269 $137 Million
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $209 Million - $271 Million
516,277 New
516,277 $209 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $24.1B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.